A pill for our market access ills?

A pill for our market access ills?
New medicines should be made available to patients in Ireland at far more sustainable prices Pic: Bloomberg

New initiatives and generic brands have reduced medicine costs for the state, but more needs to be done to improve patients’ access to new treatments

According to Atul Gawande, professor in the department of health policy and management at Harvard School of Public Health, our ever-changing world of modern medicine challenges us with 13,000 diseases, 6,000 drugs and 4,000 surgical procedures. The rapidly evolving world of medicine plays a crucial part in helping us fight sickness and disease. That is why we, as a society, should pay close attention to the approach our government, and the HSE, is taking towards...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post